• AhR Mediates MEHP Toxicity in Ovarian Follicles

  2026-09-03

  The reference study identifies aryl hydrocarbon receptor activation as a functional mediator of mono(2-ethylhexyl) phthalate toxicity in mouse ovarian antral follicles. Pharmacological AhR blockade partially restores follicle growth, estrogen production, and estrogen-responsive gene expression, providing a mechanistic framework for environmental toxicology research.

• FITC-Concanavalin A (ConA) Conjugate Guide

  2026-09-03

  FITC-Concanavalin A (ConA) Conjugate is a fluorescent lectin conjugate for detecting accessible α-D-glucose and α-D-mannose residues on glycoproteins and glycolipids in cells or tissues. It is suited to immunofluorescence staining and flow cytometry carbohydrate detection, but it should not be treated as a general protein-binding probe or used outside its defined storage and stability conditions.

• Anlotinib: Reframing Anti-Angiogenic TKI Research

  2026-09-02

  Anlotinib hydrochloride offers a translationally useful way to connect VEGFR2, PDGFRβ, and FGFR1 inhibition with endothelial phenotypes and tumor-angiogenesis biology. This thought-leadership guide explains how to interpret the evidence, design more informative assays, and move beyond product-page descriptions toward mechanism-led cancer research.

• DiD Membrane Labeling for ROS Assays

  2026-09-02

  DiD and DiDC 18 (5) provide a red fluorescent membrane readout that can complement mechanistic studies of ROS-driven macrophage inflammation. This guide develops an assay framework for membrane integrity, cell tracking, and immunofluorescence while clearly separating membrane signals from mitochondrial and inflammasome endpoints.

• CRTC–CREB Senses Proteotoxic Stress in Drosophila

  2026-09-01

  The reference study identifies CRTC–CREB as a stress-responsive transcriptional system activated by proteasome inhibition through ROS and JNK. Using Drosophila, cultured cells, transcriptomics, and a Huntington’s disease model, it shows that enhancing this pathway can improve proteostasis and reduce protein aggregation, while also defining important limits for translation to oncology and neurodegeneration research.

• EDTA-Free Protease Inhibitor Cocktail K4002

  2026-09-01

  The Protease Inhibitor Cocktail is a 100X, DMSO-based EDTA-Free Protease Inhibitor for broad protection of proteins during cell and tissue extraction. Its multi-component design supports protein stability in Western blotting, immunoprecipitation, imaging, and kinase workflows, while the cited OXPHOS study provides biological context rather than direct product validation.

• Fra2/LCN2 Links PM2.5 to Asthma Ferroptosis

  2026-08-31

  A 2026 Redox Biology study identifies Fra2-driven LCN2 activation as a mechanistic link between PM2.5 exposure, impaired mitophagy, and ferroptosis in M2 macrophages during asthma aggravation. Genetic LCN2 suppression reduced airway inflammation and improved lung function in mice, providing a framework for studying pollution-associated asthma through macrophage iron and redox biology.

• FITC-Concanavalin A (ConA) Conjugate Guide

  2026-08-31

  FITC-Concanavalin A is a fluorescent lectin conjugate for visualizing α-D-glucose and α-D-mannose residues associated with glycoproteins and glycolipids. It is appropriate for cell surface carbohydrate detection, immunofluorescence staining, and flow cytometry, but it should not be used as a universal glycan stain or as a probe for non-carbohydrate targets.

• Kitasamycin for Swine Dysentery: Evidence and Limits

  2026-08-30

  This study tested kitasamycin against Australian Brachyspira hyodysenteriae isolates and in experimentally infected pigs, linking isolate-level susceptibility with prevention and treatment outcomes. Its central practical finding is that kitasamycin controlled swine dysentery caused by a susceptible isolate, while widespread macrolide resistance limits broad therapeutic generalization.

• Z-LEHD-FMK: Irreversible Caspase-9 Inhibitor

  2026-08-29

  Z-LEHD-FMK is an irreversible caspase-9 inhibitor for dissecting mitochondria-mediated apoptosis. Its reported use spans apoptosis assays, TRAIL-rescue experiments, cancer research, and preclinical neuroprotection workflows.

• Alternariol (AOH) Workflow for Fibrosis Research

  2026-08-28

  Build a controlled AOH workflow that connects chemical exposure to LX-2 activation, apoptosis, cytochrome P450 biology, and detoxification testing. This practical guide separates literature-supported mechanisms from starting conditions for dose finding, phenotype validation, and troubleshooting.

• Hydroxychloroquine Sulfate Workflow Guide

  2026-08-28

  Hydroxychloroquine Sulfate (SKU B4874) provides an aqueous-compatible research reagent for examining TLR7/9 signaling and autophagy pathway modulation in autoimmune disease research. It is suited to short-term, water-based cellular or animal workflows, but should not be selected for protocols requiring DMSO or ethanol solubility or long-term storage of prepared solutions.

• SB-3CT: Selective Gelatinase Inhibitor

  2026-08-27

  SB-3CT is a mechanism-based gelatinase inhibitor that preferentially targets MMP-2 and also inhibits MMP-9. Its preclinical profile supports tumor metastasis research, extracellular-matrix studies, and neuroprotection in cerebral ischemia, while assay-specific potency and limited translational evidence require careful interpretation.

• Coelenterazine Workflows for ROS Assays

  2026-08-27

  Coelenterazine links luciferase-compatible reporting with chemiluminescent detection of superoxide anion and peroxynitrite. This practical guide shows how to adapt it for AVP reporter studies, BRET, oxidative stress measurement, high-throughput screening, and cancer-associated reactive oxygen species imaging while controlling solvent and signal confounders.

• Cucurbitacin I (JSI-124): STAT3 Research Guide

  2026-08-26

  Cucurbitacin I, also called JSI-124, is a research inhibitor of JAK2/STAT3 signaling with reported activity in cancer cell and xenograft models. This guide summarizes its mechanism, benchmark conditions, formulation limits, and assay applications without treating vendor-reported findings as universal biological constants.

7889 records 1/526 page Next 12345 下5页 Last page